Literature DB >> 34937738

Isolated Memory Loss in Anti-NMDAR Encephalitis.

Raffaele Iorio1, Eleonora Sabatelli2, Lucia Campetella2, Claudia Papi2.   

Abstract

BACKGROUND AND OBJECTIVES: To report a case of anti-NMDAR encephalitis presenting with isolated memory dysfunction.
METHODS: A 29-year-old woman was admitted to the Neurology Department referring memory impairment with a subacute onset. The initial assessment included EEG, neuropsychological tests, and brain MRI. Serum and CSF samples were collected for immunologic studies. The diagnostic evaluation was completed with a total body PET scan.
RESULTS: Patient's neurologic examination was unremarkable apart from an episodic memory deficit, confirmed by neuropsychological examination. The EEG revealed epileptiform discharges in the temporal lobes, whereas brain MRI showed bilateral temporal lobes hyperintense lesions on fluid-attenuated inversion recovery images and T2-weighted images. NMDAR-IgG was detected in the patient's serum and CSF by cell-based assay confirming the diagnosis of definite anti-NMDAR encephalitis. The total body PET showed only a slight hypometabolism in the right temporal cortex and in the cerebellar hemispheres. After a course of IV immunoglobulin and corticosteroid therapy, a marked improvement of the memory deficit was observed. DISCUSSION: This case shows that anti-NMDAR encephalitis can present with isolated memory loss. Neural antibody testing in these patients could play a pivotal role in early diagnosis and prompt treatment.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Entities:  

Mesh:

Year:  2021        PMID: 34937738      PMCID: PMC8696551          DOI: 10.1212/NXI.0000000000001128

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


  7 in total

1.  The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy.

Authors:  R Iorio; G Assenza; M Tombini; G Colicchio; G Della Marca; A Benvenga; V Damato; P M Rossini; C Vollono; D Plantone; A Marti; A P Batocchi; A Evoli
Journal:  Eur J Neurol       Date:  2014-08-12       Impact factor: 6.089

2.  Isolated hemidystonia associated with NMDA receptor antibodies.

Authors:  Ignacio Rubio-Agustí; Josep Dalmau; Teresa Sevilla; María Burgal; Eduardo Beltrán; Luís Bataller
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

3.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

4.  Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.

Authors:  Pitt Niehusmann; Josep Dalmau; Christian Rudlowski; Angela Vincent; Christian E Elger; Jeffrey E Rossi; Christian G Bien
Journal:  Arch Neurol       Date:  2009-04

5.  Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic aetiology.

Authors:  R Iorio; V Damato; G Spagni; G Della Marca; C Vollono; G Masi; C Papi; L Campetella; G Monte; A Evoli
Journal:  Eur J Neurol       Date:  2020-06-19       Impact factor: 6.089

6.  Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis.

Authors:  Michiel H F Poorthuis; Josephus L M van Rooij; Anna H Koch; Annelies E M Verdonkschot; Machteld M Leembruggen; Maarten J Titulaer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-04

Review 7.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.